Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I/II Study to Assess the Efficacy and Safety of Nab-paclitaxel in Combination With Gemcitabine for the Treatment of Fragile Patients With Advanced or Metastatic Pancreatic Cancer

NCT02382263 is registered in ClinicalTrials.gov with PH Research, S.L. as lead sponsor.

NCT NCT02382263
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02382263 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I/II Study to Assess the Efficacy and Safety of Nab-paclitaxel in Combination With Gemcitabine for the Treatment of Fragile Patients With Advanced or Metastatic Pancreatic Cancer
Lead sponsor
PH Research, S.L.
Phase
Phase 1/2
Overall status
Completed
Start date
April 30, 2013
Completion date
April 30, 2016
Enrollment
224 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

advanced pancreatic cancer